These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18996355)

  • 1. A novel integrin alpha5beta1 antagonistic peptide, A5-1, screened by Protein Chip system as a potent angiogenesis inhibitor.
    Kim EY; Bang JY; Chang SI; Kang IC
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1288-93. PubMed ID: 18996355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput screening of novel peptide inhibitors of an integrin receptor from the hexapeptide library by using a protein microarray chip.
    Lee Y; Kang DK; Chang SI; Han MH; Kang IC
    J Biomol Screen; 2004 Dec; 9(8):687-94. PubMed ID: 15634795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
    Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
    J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the integrin alpha5beta1 antagonist JSM6427 in proliferative vitreoretinopathy using in vitro assays and a rabbit model of retinal detachment.
    Zahn G; Volk K; Lewis GP; Vossmeyer D; Stragies R; Heier JS; Daniel PE; Adamis AP; Chapin EA; Fisher SK; Holz FG; Löffler KU; Knolle J
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1028-35. PubMed ID: 19815730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ProteoChip-based library screening of integrin alpha5beta1 antagonists from Korean medicinal plant extracts.
    Bang JI; Kim EY; Seong NS; Shin YS; Kang IC
    Arch Pharm Res; 2007 Dec; 30(12):1584-9. PubMed ID: 18254246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIVL, a snake venom Kunitz-type serine protease inhibitor, inhibits in vitro and in vivo angiogenesis.
    Morjen M; Honoré S; Bazaa A; Abdelkafi-Koubaa Z; Ellafi A; Mabrouk K; Kovacic H; El Ayeb M; Marrakchi N; Luis J
    Microvasc Res; 2014 Sep; 95():149-56. PubMed ID: 25173589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis induced by novel peptides selected from a phage display library by screening human vascular endothelial cells under different physiological conditions.
    Hardy B; Raiter A; Weiss C; Kaplan B; Tenenbaum A; Battler A
    Peptides; 2007 Mar; 28(3):691-701. PubMed ID: 17187899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agent.
    Ramakrishnan V; Bhaskar V; Law DA; Wong MH; DuBridge RB; Breinberg D; O'Hara C; Powers DB; Liu G; Grove J; Hevezi P; Cass KM; Watson S; Evangelista F; Powers RA; Finck B; Wills M; Caras I; Fang Y; McDonald D; Johnson D; Murray R; Jeffry U
    J Exp Ther Oncol; 2006; 5(4):273-86. PubMed ID: 17024968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel synthetic peptide showing angiogenic activity in human endothelial cells.
    Lee CH; Lee MS; Kim SJ; Je YT; Ryu SH; Lee T
    Peptides; 2009 Feb; 30(2):409-18. PubMed ID: 18992291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natramune and PureWay-C reduce xenobiotic-induced human T-cell alpha5beta1 integrin-mediated adhesion to fibronectin.
    Weeks BS; Lee S; Perez PP; Brown K; Chauhan H; Tsaava T
    Med Sci Monit; 2008 Dec; 14(12):BR279-85. PubMed ID: 19043362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DGDA, a local sequence of the kringle 2 domain, is a functional motif of the tissue-type plasminogen activator's antiangiogenic kringle domain.
    Kim HK; Joe YA
    Biochem Biophys Res Commun; 2010 Jan; 391(1):166-9. PubMed ID: 19903452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A horsefly saliva antigen 5-like protein containing RTS motif is an angiogenesis inhibitor.
    Ma D; Gao L; An S; Song Y; Wu J; Xu X; Lai R
    Toxicon; 2010 Jan; 55(1):45-51. PubMed ID: 19635491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of campesterol from Chrysanthemum coronarium L. and its antiangiogenic activities.
    Choi JM; Lee EO; Lee HJ; Kim KH; Ahn KS; Shim BS; Kim NI; Song MC; Baek NI; Kim SH
    Phytother Res; 2007 Oct; 21(10):954-9. PubMed ID: 17604370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of integrin alpha5beta1 in the regulation of corneal neovascularization.
    Muether PS; Dell S; Kociok N; Zahn G; Stragies R; Vossmeyer D; Joussen AM
    Exp Eye Res; 2007 Sep; 85(3):356-65. PubMed ID: 17659277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin alphavbeta3 is not significantly implicated in the anti-migratory effect of anti-angiogenic urokinase kringle domain.
    O E; Kim HK; Hong SH; Kim CK; Hong YK; Joe YA
    Oncol Rep; 2008 Sep; 20(3):631-6. PubMed ID: 18695916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parstatin, the cleaved peptide on proteinase-activated receptor 1 activation, is a potent inhibitor of angiogenesis.
    Zania P; Gourni D; Aplin AC; Nicosia RF; Flordellis CS; Maragoudakis ME; Tsopanoglou NE
    J Pharmacol Exp Ther; 2009 Feb; 328(2):378-89. PubMed ID: 18988770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand binding analysis for human alpha5beta1 integrin: strategies for designing new alpha5beta1 integrin antagonists.
    Marinelli L; Meyer A; Heckmann D; Lavecchia A; Novellino E; Kessler H
    J Med Chem; 2005 Jun; 48(13):4204-7. PubMed ID: 15974570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-angiogenic effects of Shiraiachrome A, a compound isolated from a Chinese folk medicine used to treat rheumatoid arthritis.
    Tong Y; Zhang X; Zhao W; Zhang Y; Lang J; Shi Y; Tan W; Li M; Zhang Y; Tong L; Lu H; Lin L; Ding J
    Eur J Pharmacol; 2004 Jun; 494(2-3):101-9. PubMed ID: 15212963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The small alpha5beta1 integrin antagonist, SJ749, reduces proliferation and clonogenicity of human astrocytoma cells.
    Maglott A; Bartik P; Cosgun S; Klotz P; Rondé P; Fuhrmann G; Takeda K; Martin S; Dontenwill M
    Cancer Res; 2006 Jun; 66(12):6002-7. PubMed ID: 16778170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obtustatin: a potent selective inhibitor of alpha1beta1 integrin in vitro and angiogenesis in vivo.
    Marcinkiewicz C; Weinreb PH; Calvete JJ; Kisiel DG; Mousa SA; Tuszynski GP; Lobb RR
    Cancer Res; 2003 May; 63(9):2020-3. PubMed ID: 12727812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.